# BENDAMUSTINE HYDROCHLORIDE
> **ANDA204771** · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK PHARMS LTD · Approved 2019-02-20
## Drug
- **FDA Application Number:** ANDA204771
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BENDAMUSTINE HYDROCHLORIDE
- **Generic name:** Bendamustine Hydrochloride
- **Active ingredients:** BENDAMUSTINE HYDROCHLORIDE
- **Dosage form:** POWDER
- **Route:** IV (INFUSION)
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** GLENMARK PHARMS LTD
- **First approval:** 2019-02-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204771)
---
*AI Analytics · CC0 1.0*